Gene · 406993
Papers1,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MiR-19 Family Impairs Adipogenesis by the Downregulation of the PPARγ Transcriptional Network. | Int J Mol Sci | 2022 | 36555437 | PubTator, text mining | PubMed |
| New Insights into the Phenotype Switching of Melanoma. | Cancers (Basel) | 2022 | 36551603 | PubTator, text mining | PubMed |
| Heterozygous Deletion of Chromosome 15q13.3 in a Boy with Developmental Regression, Global Developmental Delay, Hypotonia, and Short Stature. | Pediatr Rep | 2022 | 36548204 | PubTator, text mining | PubMed |
| A review of current evidence about lncRNA MEG3: A tumor suppressor in multiple cancers. | Front Cell Dev Biol | 2022 | 36544907 | PubTator, text mining | PubMed |
| Comprehensive view on genetic features, therapeutic modalities and prognostic models in adult T-cell lymphoblastic lymphoma. | Blood Sci | 2022 | 36518593 | PubTator, text mining | PubMed |
| Mir204 and Mir211 suppress synovial inflammation and proliferation in rheumatoid arthritis by targeting Ssrp1. | Elife | 2022 | 36511897 | PubTator, text mining | PubMed |
| The role of miRNAs in the diagnosis of stable atherosclerosis of different arterial territories: A critical review. | Front Cardiovasc Med | 2022 | 36505351 | PubTator, text mining | PubMed |
| Focusing on the hypoxia-inducible factor pathway: role, regulation, and therapy for osteoarthritis. | Eur J Med Res | 2022 | 36503684 | PubTator, text mining | PubMed |
| The Roles of MiRNAs (MicroRNAs) in Melanoma Immunotherapy. | Int J Mol Sci | 2022 | 36499102 | PubTator, text mining | PubMed |
| Modulation of immunosuppressive cells and noncoding RNAs as immunotherapy in osteosarcoma. | Front Immunol | 2022 | 36457998 | PubTator, text mining | PubMed |
| MicroRNAs as a possible biomarker in the treatment of multiple sclerosis. | IBRO Neurosci Rep | 2022 | 36439971 | PubTator, text mining | PubMed |
| Study on the Mechanism of miR-125b-5p Affecting Melanocyte Biological Behavior and Melanogenesis in Vitiligo through Regulation of MITF. | Dis Markers | 2022 | 36438898 | PubTator, text mining | PubMed |
| LINC00958 may be a new prognostic biomarker in various cancers: A meta-analysis and bioinformatics analysis. | Front Genet | 2022 | 36437914 | PubTator, text mining | PubMed |
| In silico and in vitro analysis of microRNAs with therapeutic potential in atherosclerosis. | Sci Rep | 2022 | 36433987 | PubTator, text mining | PubMed |
| Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics? | Molecules | 2022 | 36431766 | PubTator, text mining | PubMed |
| RUNX Proteins as Epigenetic Modulators in Cancer. | Cells | 2022 | 36429115 | PubTator, text mining | PubMed |
| Circulating Long Non-Coding RNAs Could Be the Potential Prognostic Biomarker for Liquid Biopsy for the Clinical Management of Oral Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 36428681 | PubTator, text mining | PubMed |
| MicroRNA-211 Promotes Non-Small-Cell Lung Cancer Proliferation and Invasion by Targeting MxA [Retraction]. | Onco Targets Ther | 2022 | 36415851 | PubTator, text mining | PubMed |
| RNA biomarkers for alcohol use disorder. | Front Mol Neurosci | 2022 | 36407766 | PubTator, text mining | PubMed |
| Identification of CKS2 and RRM2 as potential markers of vitiligo using bioinformatics analysis. | Medicine (Baltimore) | 2022 | 36401415 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406993/papers?page=12